Literature DB >> 28954013

Mutagenicity and antimutagenicity of Salacia crassifolia (mart. Ex. Schult.) G. Don. evaluated by Ames test.

C C Carneiro1, J Holanda Véras1, B R Lima Góes1, C N Pérez2, L Chen-Chen1.   

Abstract

Salacia crassifolia (Mart. Ex. Schult.) G. Don. is a bush which belongs to Celastraceae family and occurs specially in Brazilian Cerrado. Its leaves, stem, seeds and fruits are popularly used for several medicinal purposes, such as antitumoral, antirheumatic, anti-inflammatory and antimicrobial. In this study, the mutagenic and antimutagenic activities of S. crassifolia stem bark fractions (hexane, ethyl acetate and hydroalcoholic) were evaluated by the Ames mutagenicity assay in Salmonella typhimurium TA98 and TA100 strains. By the obtained results, all S. crassifolia fractions did not significantly increase the number of prototrophic revertants for histidine (His+) in both S. typhimurium strains tested (p > 0.05), suggesting absence of mutagenicity. Regarding antimutagenicity, the fractions ethyl acetate and hydroalcoholic significantly decreased the number of His+ revertants colonies induced by positive control for strain TA98 (p < 0.05), demonstrating protection against mutagenicity induced by 4-nitroquinolile1-oxide, whereas the hexane fraction did not show antimutagenic effect in this strain. In the TA100 strain, all fractions of S. crassifolia protected DNA against the harmful action of sodium azide, and the hexane fraction exhibited the greatest protection in this work. Thus, it's possible conclude that the fractions of S. crassifolia tested in this study could be used in chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28954013     DOI: 10.1590/1519-6984.166593

Source DB:  PubMed          Journal:  Braz J Biol        ISSN: 1519-6984            Impact factor:   1.651


  1 in total

1.  Mutagenic Study of Benzimidazole Derivatives with (+S9) and without (-S9) Metabolic Activation.

Authors:  Nurul Hafizan Azahar; Siti Soleha Ab Dullah; Rozaini Abdullah; Norizan Ahmat; Abdah Md Akim; Hasiah Ab Hamid
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.